SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex is trending due to a potential short squeeze, with community members actively discussing holding shares and targeting a run similar to other low floaters. Chatter revolves around breaking the $9 and $10 price levels, which some believe could trigger a significant surge. The stock's earlier premarket highs and comparisons to recent high-flying stocks are also fueling the conversation.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

CVNA is trending as it's set to join the S&P 500, sparking debate about its valuation and business practices; while some celebrate the stock's dramatic turnaround, others highlight concerns around its high P/E ratio and potential for a short squeeze, anticipating a possible insider dump. Community members are actively discussing whether this inclusion reflects genuine growth or a market bubble, with opinions divided between bullish expectations and bearish warnings.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a projected profit turnaround in FY25, sparking interest in this low-float stock. Community members are watching for continuation, with some drawing comparisons to recent surges in similar stocks like $TGL and anticipating after-hours momentum. The stock's low float and positive outlook are fueling speculation of a potential short squeeze.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance (PSKY) is trending amid news of a potential bidding war for Warner Bros. Discovery (WBD), with PSKY reportedly making a hostile bid. Community discussion revolves around the implications of this bid, its financing, and potential regulatory hurdles compared to Netflix's offer, with some suggesting a short squeeze may occur and some investors suggesting a hostile bid for PSKY by Netflix may be a reaction.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst news of a potential acquisition of Warner Bros. Discovery, sparking community debate around the strategic implications of the deal, including regulatory hurdles and debt concerns. Discussions also involve a competing bid from Paramount Skydance, adding uncertainty to the outcome and prompting speculation about potential deal terms and the future of the streaming landscape.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences (WVE) is surging due to positive Phase 1 trial results for its RNA-editing therapy targeting AATD, with analysts highlighting the milestone achievement in RNA editing. Community members are actively discussing the potential for a new offering and comparing WVE to other companies in the RNA editing space such as $PRQR and $KRRO.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

Treasure Global Inc. ($TGL) is trending as traders discuss its volatile price action and potential for another explosive run similar to $SMX. Community members are debating whether to hold, buy the dip, or take profits amidst the price swings, with some pointing to a revenue outlook update as a possible catalyst. The stock's low float and high short borrow rates are also fueling speculation about a potential short squeeze.

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

Fulcrum Therapeutics Inc

FULC is trending due to recent positive Phase 1b trial results for its sickle cell disease drug, pociredir, leading to analyst price target hikes and renewed community interest. Discussions revolve around the drug's potential, including strong HbF induction and a favorable safety profile, with some traders closely watching key trigger prices for potential shorting opportunities. The stock is also being discussed in the context of broader sector trends and potential for a "big pump" given high institutional ownership.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending due to positive Phase 2 clinical trial data for its oral GLP-1 obesity pill, which demonstrated significant weight loss. Community discussions revolve around the drug's potential to compete with existing treatments and the possibility of a buyout, with some analysts highlighting its best-in-class potential among oral incretins.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending due to a reported hostile takeover bid by Paramount Skydance (PSKY) at $30 per share, challenging Netflix's existing offer; community discussions focus on the potential for a bidding war and whether WBD shareholders will receive greater value from PSKY's all-cash offer versus the Netflix deal, which includes stock. The situation is further complicated by regulatory concerns and potential influence from the Trump administration, with the community speculating about which offer will ultimately prevail and what it means for the future of streaming and the media landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Most investors have no clue what Cytek Biosciences ($CTKB) actually does — and that’s exactly why it still trades like a hidden gem.
CTKB isn’t a biotech.
It’s a life-science tools company powering the infrastructure behind cell analysis.

Think “the NVIDIA of immune profiling

Avoid

Rebekah Hail

Stockbager

StockTwits For Android 

Cytek BioSciences Inc

Most investors have no clue what Cytek Biosciences (

) actually does — and that’s exactly why it still trades like a hidden gem.
CTKB isn’t a biotech.
It’s a life-science tools company powering the infrastructure behind cell analysis.

Think “the NVIDIA of immune profiling

Richard McScott

Traditional flow cytometry hits hard limits:
• limited colors
• spectral overlap
• expensive scaling
• heavy compensation issues

$CTKB’s platform breaks those constraints with full-spectrum cytometry, allowing researchers to read far more biology from the same sample.

This matters because disease is getting more complex, not less.

Traditional flow cytometry hits hard limits:
• limited colors
• spectral overlap
• expensive scaling
• heavy compensation issues



’s platform breaks those constraints with full-spectrum cytometry, allowing researchers to read far more biology from the same sample.

This matters because disease is getting more complex, not less.

Why does this tech matter in 2025–2026?

Because the next wave of breakthroughs —
• immuno-oncology
• autoimmune disease mapping
• CAR-T
• multi-omic clinical trials

— all require richer, more granular cell analysis.

$CTKB’s systems make that possible.

Why does this tech matter in 2025–2026?

Because the next wave of breakthroughs —
• immuno-oncology
• autoimmune disease mapping
• CAR-T
• multi-omic clinical trials

— all require richer, more granular cell analysis.



Business model highlights:

• High-margin instruments
• Recurring consumables → the real revenue engine
• Sticky install base
• Deep penetration in academia + clinical labs
• Expanding global distribution footprint

Once a lab installs $CTKB hardware, switching costs are massive.

That’s the moat.

Business model highlights:

• High-margin instruments
• Recurring consumables → the real revenue engine
• Sticky install base
• Deep penetration in academia + clinical labs
• Expanding global distribution footprint

Once a lab installs 

 hardware, switching costs are massive.

That’s the moat.